Log In
Print
BCIQ
Print
Print this Print this
 

ABT-450

  Manage Alerts
Collapse Summary General Information
Company AbbVie Inc.
DescriptionOral HCV NS3/4A protease inhibitor
Molecular Target HCV NS3/4A protease complex
Mechanism of ActionViral protease inhibitor
Latest Stage of DevelopmentPhase III
IndicationHepatitis C virus (HCV)
Partner

Enanta Pharmaceuticals Inc.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today